Evidence map›Paper›PMID 26937035›Full record

ArticleJournal of virology2016

Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.

Kristen L Conn, Peter Wasson, Steven McFarlane, Lily Tong, James R Brown, Kyle G Grant, Patricia Domingues, Chris Boutell

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kristen L ConnMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland, United Kingdom.
Peter WassonMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland, United Kingdom.
Steven McFarlaneMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland, United Kingdom.
Lily TongMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland, United Kingdom.
James R BrownMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland, United Kingdom.
Kyle G GrantMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland, United Kingdom.
Patricia DominguesMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland, United Kingdom.
Chris BoutellMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland, United Kingdom chris.boutell@glasgow.ac.uk.
MRC University of Glasgow Centre for Virus Research · GB

Funding

Medical Research Council MC_UP_A550_1030Medical Research Council MC_UU_12014/5
6 · The paper itself

Abstract

unlabelledSmall ubiquitin-like modifier (SUMO) is used by the intrinsic antiviral immune response to restrict viral pathogens, such as herpes simplex virus 1 (HSV-1). Despite characterization of the host factors that rely on SUMOylation to exert their antiviral effects, the enzymes that mediate these SUMOylation events remain to be defined. We show that unconjugated SUMO levels are largely maintained throughout infection regardless of the presence of ICP0, the HSV-1 SUMO-targeted ubiquitin ligase. Moreover, in the absence of ICP0, high-molecular-weight SUMO-conjugated proteins do not accumulate if HSV-1 DNA does not replicate. These data highlight the continued importance for SUMO signaling throughout infection. We show that the SUMO ligase protein inhibitor of activated STAT 4 (PIAS4) is upregulated during HSV-1 infection and localizes to nuclear domains that contain viral DNA. PIAS4 is recruited to sites associated with HSV-1 genome entry through SUMO interaction motif (SIM)-dependent mechanisms that are destabilized by ICP0. In contrast, PIAS4 accumulates in replication compartments through SIM-independent mechanisms irrespective of ICP0 expression. Depletion of PIAS4 enhances the replication of ICP0-null mutant HSV-1, which is susceptible to restriction by the intrinsic antiviral immune response. The mechanisms of PIAS4-mediated restriction are synergistic with the restriction mechanisms of a characterized intrinsic antiviral factor, promyelocytic leukemia protein, and are antagonized by ICP0. We provide the first evidence that PIAS4 is an intrinsic antiviral factor. This novel role for PIAS4 in intrinsic antiviral immunity contrasts with the known roles of PIAS proteins as suppressors of innate immunity. IMPORTANCE: Posttranslational modifications with small ubiquitin-like modifier (SUMO) proteins regulate multiple aspects of host immunity and viral replication. The protein inhibitor of activated STAT (PIAS) family of SUMO ligases is predominantly associated with the suppression of innate immune signaling. We now identify a unique and contrasting role for PIAS proteins as positive regulators of the intrinsic antiviral immune response to herpes simplex virus 1 (HSV-1) infection. We show that PIAS4 relocalizes to nuclear domains that contain viral DNA throughout infection. Depletion of PIAS4, either alone or in combination with the intrinsic antiviral factor promyelocytic leukemia protein, significantly impairs the intrinsic antiviral immune response to HSV-1 infection. Our data reveal a novel and dynamic role for PIAS4 in the cellular-mediated restriction of herpesviruses and establish a new functional role for the PIAS family of SUMO ligases in the intrinsic antiviral immune response to DNA virus infection.

Indexed as

Host-Pathogen InteractionsAmino Acid MotifsAmino Acid SequenceCell LineDisease ProgressionDNA ReplicationDNA, ViralGene ExpressionGenome, ViralHerpes SimplexHerpesvirus 1, HumanHumansImmediate-Early ProteinsImmunity, InnateMutationNuclear ProteinsDNA, ViralImmediate-Early ProteinsNuclear ProteinsPML protein, humanPromyelocytic Leukemia ProteinProtein Inhibitors of Activated STATRecombinant Fusion ProteinsSUMO-1 ProteinTranscription FactorsTumor Suppressor ProteinsUbiquitin-Protein LigasesVmw110 protein, Human herpesvirus 1

Identifiers

PMID26937035
PMCPMC4836348
OpenAlexW2292398521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.